BCAL Diagnostics Limited is an Australian biotechnology screening and diagnostic company dedicated to achieving early and accurate breast cancer diagnoses. Our mission is to facilitate early intervention, ultimately leading to improved outcomes for women. For more than a decade, BCAL has been at the forefront of developing non-invasive technologies to assist clinicians in detecting breast cancer. Our cutting-edge technology is designed to complement existing imaging techniques such as mammograms. Our innovative test aims to evolve into a comprehensive monitoring and screening tool accessible to women of all ages and backgrounds, regardless of location.
